查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930111

全球電生理設備市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Electrophysiology Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 請詢問到貨日

價格

電生理設備市場成長因素

由於心律不整盛行率的上升以及先進心臟介入療法的廣泛應用，全球電生理設備市場正經歷著穩定成長。電生理設備廣泛用於診斷和治療心律不整，例如心房顫動、室上性心動過速和室性心動過速。 這些設備包括消融導管、診斷導管、標測系統及相關配件，可幫助臨床醫師準確識別及治療心臟內的異常電傳導路徑。

根據 Fortune Business Insights 數據顯示，2025 年全球電生理設備市場規模為 79 億美元。預計該市場規模將從 2026 年的 87.6 億美元增長至 2034 年的 201 億美元，預測期內（2026-2034 年）複合年增長率 (CAGR) 為 10.95%。北美地區在 2025 年佔市場主導地位，佔全球市場佔有率的 34.48%，這主要得益於該地區較高的疾病盛行率和有利的報銷政策。

市場規模與關鍵指標

  • 市場規模（2025 年）：79 億美元
  • 市場規模（2026 年）：87.6 億美元
  • 市場預測（2034 年）：201 億美元
  • 複合年增長率（2026-2034 年）：10.95%
  • 主要地區（2025 年）：北美（34.48% 的市佔率）

心血管疾病的日益增加以及對微創消融手術需求的成長是市場擴張的主要驅動因素。

新冠疫情的影響

新冠疫情對電生理設備市場產生了複雜的影響。 先前患有心臟病的患者發生心肌損傷、心肌炎和心臟衰竭的風險更高，而新冠疫情促使擇期心臟手術數量急劇下降。研究表明，2020年初美國急性心肌梗塞住院人數下降了40-50%。同樣，2020年上半年義大利急性心肌梗塞住院人數下降了49.4%。這一下降暫時降低了對電生理設備的需求，影響了主要市場參與者的收入。

市場趨勢

推動市場發展的關鍵趨勢是電生理系統的技術進步，特別是標測和消融技術。在北美，受先進標測和成像系統引入的推動，市場規模預計將從2025年的27.2億美元增長到2026年的30億美元。 配備感測器和力感應消融導管的引入顯著提高了手術精確度和臨床療效。

市場驅動因素

心律不整盛行率的上升是市場成長的主要驅動因素。根據美國疾病管制與預防中心 (CDC) 統計，美國有 270 萬至 600 萬人患有心房顫動，且其盛行率隨年齡增加而顯著增加。光是室性心搏過速每年就導緻美國約 30 萬人死亡。人們對心律不整的認識不斷提高，早期診斷得以普及，以及導管消融手術的廣泛應用，正在推動全球對電生理設備的需求。

市場限制因子

儘管市場成長前景強勁，但仍面臨諸多挑戰，例如產品頻繁召回以及某些地區保險覆蓋範圍有限。消融導管及相關配件的召回引發了安全擔憂，並減緩了其推廣應用。 此外，發展中國家高昂的手術費用和不足的保險覆蓋範圍限制了市場滲透率。

細分市場分析

依類型劃分，市場可分為消融導管、診斷導管、標測系統、配件和其他。 預計到 2026 年，消融導管市場佔有率將達到 38.77%，主要得益於其在心房顫動治療中應用日益廣泛。

依應用領域劃分，預計到 2026 年，室上性心動過速 (SVT) 將佔最大的市場佔有率，達到 39.23%，這主要得益於導管消融手術的高成功率。

依終端用戶劃分，醫院和門診手術中心 (ASC) 將在 2026 年佔市場主導地位，市場佔有率達到 78.48%，這主要得益於其高手術量和先進的基礎設施。

依地區分析

  • 北美：預計到 2025 年，市場規模將達到 27.2 億美元，主要得益於心律不整的高發生率和健保報銷政策的支持。
  • 歐洲：心房顫動盛行率的上升，尤其是在德國和英國，推動了市場成長。
  • 亞太地區：由於醫療基礎設施的不斷完善和疾病負擔的加重，預計該地區將以顯著的複合年增長率增長。
  • 拉丁美洲、中東和非洲：由於先進的電生理實驗室資源有限且普及率較低，預計該地區的成長速度將放緩。

主要公司

在該市場營運的主要公司包括雅培、美敦力、波士頓科學、強生服務公司、Stereotax、Attricure、AngioDynamics 和 Biotronik。這些公司正致力於產品創新、併購和獲得監管部門的批准，以加強其全球影響力。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇

第四章：關鍵考慮因素

  • 主要公司新產品發布
  • 主要地區和國家心搏過速盛行率（2025 年）
  • 電生理設備技術進步
  • 關鍵趨勢：併購、業務合作
  • 新冠疫情對電生理設備市場的影響

第五章：全球電生理設備市場分析：洞察與預測 (2021-2034)

  • 關鍵分析/摘要
  • 市場分析、洞察與預測：依類型劃分
    • 消融導管
    • 診斷導管
    • 標測系統
    • 配件
    • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 心房顫動
    • 室上性心搏過速（SV Tachycardia）
    • 室性心搏過速
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和門診手術中心 (ASC)
    • 專科診所和診斷中心
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美電生理設備市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲電生理設備市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章亞太地區電生理設備市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲電生理設備市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲電生理設備市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家/地區
    • 南非
    • 中東和非洲其他地區

第十一章：競爭分析

  • 主要行業趨勢
  • 全球市佔率分析（2025 年）
  • 公司簡介
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Johnson &Johnson Services, Inc.
  • Stereotaxis, Inc.
  • AngioDynamics
  • Biotronik, Inc.
  • Other Prominent Players

第十二章：策略建議

Product Code: FBI101730

Growth Factors of electrophysiology devices Market

The global electrophysiology devices market is witnessing steady growth due to the rising prevalence of cardiac rhythm disorders and increasing adoption of advanced interventional cardiology procedures. Electrophysiology devices are widely used for the diagnosis and treatment of heart rhythm abnormalities such as atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. These devices include ablation catheters, diagnostic catheters, mapping systems, and related accessories that help clinicians precisely identify and treat abnormal electrical pathways in the heart.

According to Fortune Business Insights, the global electrophysiology devices market was valued at USD 7.9 billion in 2025. The market is projected to grow from USD 8.76 billion in 2026 to USD 20.1 billion by 2034, exhibiting a CAGR of 10.95% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for 34.48% of the global market share, supported by high disease prevalence and favorable reimbursement policies.

Market Size and Key Metrics

  • 2025 Market Size: USD 7.9 billion
  • 2026 Market Size: USD 8.76 billion
  • 2034 Forecast Market Size: USD 20.1 billion
  • CAGR (2026-2034): 10.95%
  • Leading Region (2025): North America (34.48% share)

The increasing burden of cardiovascular diseases and growing preference for minimally invasive ablation procedures are key contributors to market expansion.

Impact of COVID-19

The COVID-19 pandemic had a mixed impact on the electrophysiology devices market. While patients with pre-existing heart conditions faced higher risks of myocardial injury, myocarditis, and heart failure, the pandemic also led to a sharp decline in elective cardiac procedures. Studies reported a 40-50% decline in hospital admissions for acute myocardial infarction in the U.S. during early 2020. Similarly, Italy witnessed a 49.4% reduction in hospital admissions for acute myocardial infarction in the first half of 2020. This decline temporarily reduced demand for electrophysiology devices and affected revenues of key market players.

Market Trends

A major trend driving the market is technological advancement in electrophysiology systems, particularly in mapping and ablation technologies. North America witnessed market growth from USD 2.72 billion in 2025 to USD 3.0 billion in 2026, supported by the adoption of advanced mapping and imaging systems. The introduction of sensor-enabled and force-sensing ablation catheters has significantly improved procedural accuracy and clinical outcomes.

Market Drivers

The rising prevalence of cardiac arrhythmias is a key driver of market growth. According to the CDC, atrial fibrillation affects 2.7 to 6.0 million people in the U.S., and its prevalence increases significantly with age. Ventricular tachycardia alone accounts for approximately 300,000 deaths annually in the U.S. Increasing awareness, early diagnosis, and the growing use of catheter-based ablation procedures are driving demand for electrophysiology devices globally.

Market Restraints

Despite strong growth prospects, the market faces challenges such as frequent product recalls and limited reimbursement coverage in certain regions. Recalls related to ablation catheters and associated accessories have raised safety concerns and slowed adoption. Additionally, high procedural costs and inadequate reimbursement in developing countries limit market penetration.

Segmentation Analysis

By Type, the market is segmented into ablation catheters, diagnostic catheters, mapping systems, accessories, and others. The ablation catheters segment is expected to hold a 38.77% share in 2026, driven by increasing use in atrial fibrillation treatment.

By Application, supraventricular tachycardia (SVT) dominated with a 39.23% share in 2026, owing to the high success rate of catheter ablation procedures.

By End User, hospitals and ambulatory surgical centers (ASCs) dominated the market with a 78.48% share in 2026, supported by higher procedure volumes and advanced infrastructure.

Regional Analysis

  • North America: Market size reached USD 2.72 billion in 2025, driven by high arrhythmia prevalence and reimbursement support.
  • Europe: Growth supported by increasing atrial fibrillation prevalence, particularly in Germany and the U.K.
  • Asia Pacific: Expected to grow at a significant CAGR due to expanding healthcare infrastructure and rising disease burden.
  • Latin America & Middle East & Africa: Moderate growth due to underpenetration and limited access to advanced EP labs.

Key Industry Players

Leading companies operating in the market include Abbott, Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Stereotaxis, AtriCure, AngioDynamics, and Biotronik. These players focus on product innovation, mergers, and regulatory approvals to strengthen their global presence.

Conclusion

In conclusion, the global electrophysiology devices market is set for strong growth from 2025 to 2034, driven by rising cardiovascular disease prevalence, technological innovation, and increasing adoption of catheter-based ablation procedures. With the market projected to grow from USD 7.9 billion in 2025 to USD 20.1 billion by 2034, electrophysiology devices will remain a cornerstone of advanced cardiac care. Continued innovation, improved reimbursement frameworks, and expanding healthcare infrastructure-especially in emerging markets-will play a critical role in shaping the future of this industry.

Segmentation

By Type

  • Ablation Catheters
  • Diagnostic Catheters
  • Mapping System
  • Accessories
  • Others

By Application

  • Atrial Fibrillation
  • Supraventricular Tachycardia (SVT)
  • Ventricular Tachycardia
  • Others

By End User

  • Hospitals & ASCs
  • Specialty Clinics & Diagnostic Centers

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. New Product Launches by Key Market Players
  • 4.2. Prevalence of Tachycardia by Key Regions/ Key Countries, 2025
  • 4.3. Technological Advancements in Electrophysiology Devices
  • 4.4. Key industry Developments - Mergers, Acquisitions and Partnerships
  • 4.5. Impact of COVID-19 on Electrophysiology Devices Market

5. Global Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Ablation Catheters
    • 5.2.2. Diagnostic Catheters
    • 5.2.3. Mapping System
    • 5.2.4. Accessories
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Atrial Fibrillation
    • 5.3.2. Supraventricular Tachycardia (SVT)
    • 5.3.3. Ventricular Tachycardia
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Hospitals & ASC's
    • 5.4.2. Specialty Clinics & Diagnostic Centers
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Ablation Catheters
    • 6.2.2. Diagnostic Catheters
    • 6.2.3. Mapping System
    • 6.2.4. Accessories
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Atrial Fibrillation
    • 6.3.2. Supraventricular Tachycardia (SVT)
    • 6.3.3. Ventricular Tachycardia
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Hospitals & ASC's
    • 6.4.2. Specialty Clinics & Diagnostic Centers
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Ablation Catheters
    • 7.2.2. Diagnostic Catheters
    • 7.2.3. Mapping System
    • 7.2.4. Accessories
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Atrial Fibrillation
    • 7.3.2. Supraventricular Tachycardia (SVT)
    • 7.3.3. Ventricular Tachycardia
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Hospitals & ASC's
    • 7.4.2. Specialty Clinics & Diagnostic Centers
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Ablation Catheters
    • 8.2.2. Diagnostic Catheters
    • 8.2.3. Mapping System
    • 8.2.4. Accessories
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Atrial Fibrillation
    • 8.3.2. Supraventricular Tachycardia (SVT)
    • 8.3.3. Ventricular Tachycardia
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Hospitals & ASC's
    • 8.4.2. Specialty Clinics & Diagnostic Centers
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Ablation Catheters
    • 9.2.2. Diagnostic Catheters
    • 9.2.3. Mapping System
    • 9.2.4. Accessories
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Atrial Fibrillation
    • 9.3.2. Supraventricular Tachycardia (SVT)
    • 9.3.3. Ventricular Tachycardia
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Hospitals & ASC's
    • 9.4.2. Specialty Clinics & Diagnostic Centers
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Ablation Catheters
    • 10.2.2. Diagnostic Catheters
    • 10.2.3. Mapping System
    • 10.2.4. Accessories
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Atrial Fibrillation
    • 10.3.2. Supraventricular Tachycardia (SVT)
    • 10.3.3. Ventricular Tachycardia
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Hospitals & ASC's
    • 10.4.2. Specialty Clinics & Diagnostic Centers
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.5.1. GCC Countries
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2025)
  • 11.3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
    • 11.3.1. Abbott
      • 11.3.1.1. Overview,
      • 11.3.1.2. Products,
      • 11.3.1.3. SWOT Analysis,
      • 11.3.1.4. Recent Developments,
      • 11.3.1.5. Strategies,
      • 11.3.1.6. Financials (based on availability)
    • 11.3.2. Medtronic
      • 11.3.2.1. Overview,
      • 11.3.2.2. Products,
      • 11.3.2.3. SWOT Analysis,
      • 11.3.2.4. Recent Developments,
      • 11.3.2.5. Strategies,
      • 11.3.2.6. Financials (based on availability)
    • 11.3.3. Boston Scientific Corporation
      • 11.3.3.1. Overview,
      • 11.3.3.2. Products,
      • 11.3.3.3. SWOT Analysis,
      • 11.3.3.4. Recent Developments,
      • 11.3.3.5. Strategies,
      • 11.3.3.6. Financials (based on availability)
    • 11.3.4. Johnson & Johnson Services, Inc.
      • 11.3.4.1. Overview,
      • 11.3.4.2. Products,
      • 11.3.4.3. SWOT Analysis,
      • 11.3.4.4. Recent Developments,
      • 11.3.4.5. Strategies,
      • 11.3.4.6. Financials (based on availability)
    • 11.3.5. Stereotaxis, Inc.
      • 11.3.5.1. Overview,
      • 11.3.5.2. Products,
      • 11.3.5.3. SWOT Analysis,
      • 11.3.5.4. Recent Developments,
      • 11.3.5.5. Strategies,
      • 11.3.5.6. Financials (based on availability)
    • 11.3.6. AngioDynamics
      • 11.3.6.1. Overview,
      • 11.3.6.2. Products,
      • 11.3.6.3. SWOT Analysis,
      • 11.3.6.4. Recent Developments,
      • 11.3.6.5. Strategies,
      • 11.3.6.6. Financials (based on availability)
    • 11.3.7. Biotronik, Inc.
      • 11.3.7.1. Overview,
      • 11.3.7.2. Products,
      • 11.3.7.3. SWOT Analysis,
      • 11.3.7.4. Recent Developments,
      • 11.3.7.5. Strategies,
      • 11.3.7.6. Financials (based on availability)
    • 11.3.8. Other Prominent Players
      • 11.3.8.1. Overview,
      • 11.3.8.2. Products,
      • 11.3.8.3. SWOT Analysis,
      • 11.3.8.4. Recent Developments,
      • 11.3.8.5. Strategies,
      • 11.3.8.6. Financials (based on availability)

12. Strategic Recommendations

List of Tables

  • Table 01: Global Electrophysiology Devices Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 02: Global Electrophysiology Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 03: Global Electrophysiology Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 04: Global Electrophysiology Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 05: North America Electrophysiology Devices Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 06: North America Electrophysiology Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 07: North America Electrophysiology Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 08: North America Electrophysiology Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 09: Europe Electrophysiology Devices Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 10: Europe Electrophysiology Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Electrophysiology Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: Europe Electrophysiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Electrophysiology Devices Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Asia Pacific Electrophysiology Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Electrophysiology Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Electrophysiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Electrophysiology Devices Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 18: Latin America Electrophysiology Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Electrophysiology Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Latin America Electrophysiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Electrophysiology Devices Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Middle East & Africa Electrophysiology Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Electrophysiology Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Middle East & Africa Electrophysiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Electrophysiology Devices Market Revenue Breakdown (USD billion, %) by Region, 2025& 2034
  • Figure 02: Global Electrophysiology Devices Market Value Share (%), by Product, 2025& 2034
  • Figure 03: Global Electrophysiology Devices Market Forecast (USD billion), by Ablation Catheters, 2021-2034
  • Figure 04: Global Electrophysiology Devices Market Forecast (USD billion), by Diagnostic Catheters, 2021-2034
  • Figure 05: Global Electrophysiology Devices Market Forecast (USD billion), by Mapping System, 2021-2034
  • Figure 06: Global Electrophysiology Devices Market Forecast (USD billion), by Accessories, 2021-2034
  • Figure 07: Global Electrophysiology Devices Market Forecast (USD billion), by Others, 2021-2034
  • Figure 08: Global Electrophysiology Devices Market Value Share (%), by Application, 2025& 2034
  • Figure 09: Global Electrophysiology Devices Market Forecast (USD billion), by Atrial Fibrillation, 2021-2034
  • Figure 10: Global Electrophysiology Devices Market Forecast (USD billion), by Supraventricular Tachycardia (SVT), 2021-2034
  • Figure 11: Global Electrophysiology Devices Market Forecast (USD billion), by Ventricular Tachycardia, 2021-2034
  • Figure 12: Global Electrophysiology Devices Market Forecast (USD billion), by Others, 2021-2034
  • Figure 13: Global Electrophysiology Devices Market Value Share (%), by End-user, 2025& 2034
  • Figure 14: Global Electrophysiology Devices Market Forecast (USD billion), by Hospitals and ASCs, 2021-2034
  • Figure 15: Global Electrophysiology Devices Market Forecast (USD billion), by Specialty Clinics and Diagnostic Centers, 2021-2034
  • Figure 16: Global Electrophysiology Devices Market Value (USD billion), by Region, 2025& 2034
  • Figure 17: North America Electrophysiology Devices Market Value (USD billion), by Product, 2025& 2034
  • Figure 18: North America Electrophysiology Devices Market Value Share (%), by Product, 2025
  • Figure 19: North America Electrophysiology Devices Market Value (USD billion), by Application, 2025& 2034
  • Figure 20: North America Electrophysiology Devices Market Value Share (%), by Application, 2025
  • Figure 21: North America Electrophysiology Devices Market Value (USD billion), by End-user, 2025& 2034
  • Figure 22: North America Electrophysiology Devices Market Value Share (%), by End-user, 2025
  • Figure 23: North America Electrophysiology Devices Market Value (USD billion), By Country, 2025& 2034
  • Figure 24: North America Electrophysiology Devices Market Value Share (%), By Country, 2025
  • Figure 25: Europe Electrophysiology Devices Market Value (USD billion), by Product, 2025& 2034
  • Figure 26: Europe Electrophysiology Devices Market Value Share (%), by Product, 2025
  • Figure 27: Europe Electrophysiology Devices Market Value (USD billion), by Application, 2025& 2034
  • Figure 28: Europe Electrophysiology Devices Market Value Share (%), by Application, 2025
  • Figure 29: Europe Electrophysiology Devices Market Value (USD billion), by End-user, 2025& 2034
  • Figure 30: Europe Electrophysiology Devices Market Value Share (%), by End-user, 2025
  • Figure 31: Europe Electrophysiology Devices Market Value (USD billion), By Country/ Sub-region, 2025& 2034
  • Figure 32: Europe Electrophysiology Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 33: Asia Pacific Electrophysiology Devices Market Value (USD billion), by Product, 2025& 2034
  • Figure 34: Asia Pacific Electrophysiology Devices Market Value Share (%), by Product, 2025
  • Figure 35: Asia Pacific Electrophysiology Devices Market Value (USD billion), by Application, 2025& 2034
  • Figure 36: Asia Pacific Electrophysiology Devices Market Value Share (%), by Application, 2025
  • Figure 37: Asia Pacific Electrophysiology Devices Market Value (USD billion), by End-user, 2025& 2034
  • Figure 38: Asia Pacific Electrophysiology Devices Market Value Share (%), by End-user, 2025
  • Figure 39: Asia Pacific Electrophysiology Devices Market Value (USD billion), By Country/ Sub-region, 2025& 2034
  • Figure 40: Asia Pacific Electrophysiology Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 41: Latin America Electrophysiology Devices Market Value (USD billion), by Product, 2025& 2034
  • Figure 42: Latin America Electrophysiology Devices Market Value Share (%), by Product, 2025
  • Figure 43: Latin America Electrophysiology Devices Market Value (USD billion), by Application, 2025& 2034
  • Figure 44: Latin America Electrophysiology Devices Market Value Share (%), by Application, 2025
  • Figure 45: Latin America Electrophysiology Devices Market Value (USD billion), by End-user, 2025& 2034
  • Figure 46: Latin America Electrophysiology Devices Market Value Share (%), by End-user, 2025
  • Figure 47: Latin America Electrophysiology Devices Market Value (USD billion), By Country/ Sub-region, 2025& 2034
  • Figure 48: Latin America Electrophysiology Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 49: Middle East & Africa Electrophysiology Devices Market Value (USD billion), by Product, 2025& 2034
  • Figure 50: Middle East & Africa Electrophysiology Devices Market Value Share (%), by Product, 2025
  • Figure 51: Middle East & Africa Electrophysiology Devices Market Value (USD billion), by Application, 2025& 2034
  • Figure 52: Middle East & Africa Electrophysiology Devices Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Electrophysiology Devices Market Value (USD billion), by End-user, 2025& 2034
  • Figure 54: Middle East & Africa Electrophysiology Devices Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Electrophysiology Devices Market Value (USD billion), By Country/ Sub-region, 2025& 2034
  • Figure 56: Middle East & Africa Electrophysiology Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Electrophysiology Devices Market Share (%), By Company, 2025